logo

ECLIPSYS C(NSDQ:ECLP)
Eclipsys Corporation is a healthcare information technology companydelivering solutions that enable healthcare providers to achieve improvedclinical, financial and administrative outcomes. Eclipsys offers an integrated suite of healthcare products in five critical areas -- clinical management, access management, patient financial management, strategic decision support and integration. Eclipsys'' products have been designed to deliver a measurable impact on outcomes, enabling Eclipsys'' customers to quantify clinical benefits and return on investment.
# Employees: 2800
Address: Three Ravinia Drive,Atlanta,GA,USA
Phone: 404 847-5000
Fax: 404-847-5700
Website: www.eclipsys.com
Email: proposals@eclipsys.com
Sector: Medical
Industry: MEDICAL INFO SYS
Executive Officers
Andrew R. Eckert (Presi.; C.E.O.; Dir.)
Robert J. Colletti (Sr. V.P.; C.F.O.; Chief Acctg. Off.)
Dan L. Crippen (Dir.)
Steven A. Denning (Dir.)
Eugene V. Fife (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/23/2010
Mean EPS (Next Qtr): $0.08
Mean EPS (Year): $0.38
Mean Estimate(Long Term): $17.11
P/E Ratio(Based on EPS estimate): 49.160
Number of Estimates: 12
Shares Performance
Period ECLP Compare to S&P
YTD 31.08 % 8.47 %
4 Weeks -0.80 % -5.83 %
12 Weeks 9.28 % 1.76 %
Shares Information
Analyst Coverage: Y
Avg Volume: 442763
Shares Outstanding: 56M
Market Cap: $1.05B
52 Week High: $21.06
52 Week Low: $7.47
P/E Ratio: 68.890
PEG Ratio: 2.870
Split: On 1/1/1990 ECLP split by factor of 0.200
Earnings Performance
EPS Growth in Last Quarter: -22.22 %
EPS Growth in Last Year: -63.16 %
Sales Growth in Last Quarter: -3.36 %
Sales Growth in Last Quarter: -5.24 %
Financials
Qtr Book Value: $2.55
Cash Flow/Share: $14.44
Change in Payout Ratio: -0.010
Price/Sales: 2.050
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia